Infinity Pharmaceuticals Raises $20 Million Through an Innovative Non-Dilutive Asset-Backed Financing from BVF
— Fully funds all ongoing IPI-549 clinical trials through key data readouts — — Non-dilutive financing extends cash runway into…
Pharmaceuticals, Biotechnology and Life Sciences
— Fully funds all ongoing IPI-549 clinical trials through key data readouts — — Non-dilutive financing extends cash runway into…
— Fully funds all ongoing IPI-549 clinical trials through key data readouts — — Non-dilutive financing extends cash runway into…
Presentation and Q&A breakout to be webcast on January 13, 2020 beginning at 2:30 p.m. Pacific Time Several clinical milestones…
SHANGHAI & ST. HELIER, Jersey–(BUSINESS WIRE)–Zai Lab Limited (NASDAQ: ZLAB), a China and U.S.-based innovative commercial stage biopharmaceutical company, and…
SHANGHAI & ST. HELIER, Jersey–(BUSINESS WIRE)–Zai Lab Limited (NASDAQ: ZLAB), a China and U.S.-based innovative commercial stage biopharmaceutical company, and…
This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014. NEW YORK & LONDON–(BUSINESS WIRE)–Tiziana…
This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014. NEW YORK & LONDON–(BUSINESS WIRE)–Tiziana…
VANCOUVER, British Columbia–(BUSINESS WIRE)–#cancergenomics–Contextual Genomics, a leading cancer genomics company, announced that it has named Brady Davis to its executive…
VANCOUVER, British Columbia–(BUSINESS WIRE)–#cancergenomics–Contextual Genomics, a leading cancer genomics company, announced that it has named Brady Davis to its executive…
MILAN & MORRISTOWN, N.J.–(BUSINESS WIRE)–$NWRN—Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of…